Beam Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Beam Therapeutics Inc. (BEAM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 310.62 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-04
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 152.95K shares, a 41.25% decline year-over-year.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 157.67K shares, a 161.65% increase year-over-year.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 158.04K shares, a 52.60% decline year-over-year.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 195.86K shares, a 17.79% decline year-over-year.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 674.51K shares, a 14.11% decline from fiscal 2024.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 785.29K shares, a 5.56% decline from fiscal 2023.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 831.49K shares, a 283.86% increase from fiscal 2022.
- Beam Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 216.61K shares, a 83.47% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 152.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 310.62K shares 10-Q · filed 2026-08-04 | 468.66K shares derived: sum of 3 quarters · filed 2026-08-04 | 664.52K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 157.67K shares 10-Q · filed 2026-05-07 | 315.71K shares derived: sum of 2 quarters · filed 2026-05-07 | 511.57K shares derived: sum of 3 quarters · filed 2026-05-07 | 771.92K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 158.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 353.90K shares derived: sum of 2 quarters · filed 2026-02-24 | 614.25K shares derived: sum of 3 quarters · filed 2026-02-24 | 674.51K shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 195.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 456.20K shares derived: sum of 2 quarters · filed 2025-11-04 | 516.46K shares 10-Q · filed 2025-11-04 | 849.92K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 260.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 320.61K shares 10-Q · filed 2025-08-05 | 654.07K shares derived: sum of 3 quarters · filed 2025-08-05 | 892.31K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 60.26K shares 10-Q · filed 2025-05-06 | 393.72K shares derived: sum of 2 quarters · filed 2025-05-06 | 631.97K shares derived: sum of 3 quarters · filed 2025-05-06 | 744.46K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 333.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 571.71K shares derived: sum of 2 quarters · filed 2025-02-25 | 684.20K shares derived: sum of 3 quarters · filed 2025-02-25 | 785.29K shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 238.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 350.74K shares derived: sum of 2 quarters · filed 2024-11-05 | 451.83K shares 10-Q · filed 2024-11-05 | 821.49K shares derived: sum of 4 quarters · filed 2024-11-05 |
| 2024-06-30 | 112.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 213.58K shares 10-Q · filed 2024-08-06 | 583.24K shares derived: sum of 3 quarters · filed 2024-08-06 | 739.41K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 101.09K shares 10-Q · filed 2024-05-07 | 470.75K shares derived: sum of 2 quarters · filed 2024-05-07 | 626.92K shares derived: sum of 3 quarters · filed 2024-05-07 | 803.12K shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 369.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 525.83K shares derived: sum of 2 quarters · filed 2024-02-27 | 702.03K shares derived: sum of 3 quarters · filed 2024-02-27 | 831.49K shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 156.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 332.37K shares derived: sum of 2 quarters · filed 2023-11-08 | 461.83K shares 10-Q · filed 2023-11-08 | 568.91K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 176.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 305.65K shares 10-Q · filed 2023-08-08 | 412.74K shares derived: sum of 3 quarters · filed 2023-08-08 | 445.92K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 129.46K shares 10-Q · filed 2023-05-10 | 236.54K shares derived: sum of 2 quarters · filed 2023-05-10 | 269.72K shares derived: sum of 3 quarters · filed 2023-05-10 | 325.43K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 107.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 140.26K shares derived: sum of 2 quarters · filed 2023-02-28 | 195.97K shares derived: sum of 3 quarters · filed 2023-02-28 | 216.61K shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 33.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 88.89K shares derived: sum of 2 quarters · filed 2022-11-07 | 109.53K shares 10-Q · filed 2022-11-07 | 166.61K shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 55.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 76.35K shares 10-Q · filed 2022-08-09 | 133.43K shares derived: sum of 3 quarters · filed 2022-08-09 | 161.68K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 20.64K shares 10-Q · filed 2022-05-09 | 77.72K shares derived: sum of 2 quarters · filed 2022-05-09 | 105.97K shares derived: sum of 3 quarters · filed 2022-05-09 | 117.01K shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 57.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 85.33K shares derived: sum of 2 quarters · filed 2022-02-28 | 96.37K shares derived: sum of 3 quarters · filed 2022-02-28 | 118.06K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 28.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 39.29K shares derived: sum of 2 quarters · filed 2021-11-08 | 60.98K shares 10-Q · filed 2021-11-08 | 109.21K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 11.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 32.73K shares 10-Q · filed 2021-08-10 | 80.96K shares derived: sum of 3 quarters · filed 2021-08-10 | 90.08K shares derived: sum of 4 quarters · filed 2021-08-10 |
| 2021-03-31 | 21.69K shares 10-Q · filed 2021-05-11 | 69.92K shares derived: sum of 2 quarters · filed 2021-05-11 | 79.04K shares derived: sum of 3 quarters · filed 2021-05-11 | 85.88K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | 48.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 57.35K shares derived: sum of 2 quarters · filed 2021-03-15 | 64.19K shares derived: sum of 3 quarters · filed 2021-03-15 | 81.98K shares 10-K · filed 2021-03-15 |
| 2020-09-30 | 9.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 15.97K shares derived: sum of 2 quarters · filed 2020-11-10 | 33.75K shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 6.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 24.63K shares 10-Q · filed 2020-08-12 | ||
| 2020-03-31 | 17.78K shares 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |